Endocrine Society GUIDELINES Bundle (free trial)

Primary Adrenal Insufficiency

Endocrine Society GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1140169

Contents of this Issue

Navigation

Page 5 of 11

6 Diagnosis Table 2. Major Etiologies of PAI and Associated Features (cont'd) Etiology Associated Features ACTH insensitivity syndromes Type 1: ACTH receptor, melanocortin 2 receptor gene MC2R Type 2: MRAP Familial glucocorticoid deficiency (MCM4, NNT, TXNRD2) TripleA (Allgrove's) syndrome, achalasia, Addison's disease, alacrima, AAAS gene mutation Drug-induced Adrenal enzyme inhibitors: mitotane, ketoconazole, metyrapone, etomidate, aminoglutethimide, drugs that may accelerate cortisol metabolism and induce adrenal insufficiency T4 also accelerates cortisol metabolism (at least in part through stimulation of 11β-HSD2) CTLA-4 inhibitors may enhance autoimmunity and cause PAI Other metabolic disorders Mitochondrial disease (rare) Adrenoleukodystrophy in males Wolman's disease Derived from E. Charmandari E, et al: Adrenal insufficiency. Lancet. 2014;383:2152– 2167, with permission. © Elsevier.

Articles in this issue

Archives of this issue

view archives of Endocrine Society GUIDELINES Bundle (free trial) - Primary Adrenal Insufficiency